Abstract

PurposeButyrate, a short-chain fatty acid derived from dietary fiber, inhibits proliferation and induces cell death in colorectal cancer cells. However, clinical trials have shown mixed results regarding the anti-tumor activities of butyrate. We have previously shown that sodium butyrate increases endoplasmic reticulum stress by altering intracellular calcium levels, a well-known autophagy trigger. Here, we investigated whether sodium butyrate-induced endoplasmic reticulum stress mediated autophagy, and whether there was crosstalk between autophagy and the sodium butyrate-induced apoptotic response in human colorectal cancer cells.MethodsHuman colorectal cancer cell lines (HCT-116 and HT-29) were treated with sodium butyrate at concentrations ranging from 0.5–5mM. Cell proliferation was assessed using MTT tetrazolium salt formation. Autophagy induction was confirmed through a combination of Western blotting for associated proteins, acridine orange staining for acidic vesicles, detection of autolysosomes (MDC staining), and electron microscopy. Apoptosis was quantified by flow cytometry using standard annexinV/propidium iodide staining and by assessing PARP-1 cleavage by Western blot.ResultsSodium butyrate suppressed colorectal cancer cell proliferation, induced autophagy, and resulted in apoptotic cell death. The induction of autophagy was supported by the accumulation of acidic vesicular organelles and autolysosomes, and the expression of autophagy-associated proteins, including microtubule-associated protein II light chain 3 (LC3-II), beclin-1, and autophagocytosis-associated protein (Atg)3. The autophagy inhibitors 3-methyladenine (3-MA) and chloroquine inhibited sodium butyrate induced autophagy. Furthermore, sodium butyrate treatment markedly enhanced the expression of endoplasmic reticulum stress-associated proteins, including BIP, CHOP, PDI, and IRE-1a. When endoplasmic reticulum stress was inhibited by pharmacological (cycloheximide and mithramycin) and genetic (siRNA targeting BIP and CHOP) methods, the induction of BIP, PDI, IRE1a, and LC3-II was blocked, but PARP cleavage was markedly enhanced.DiscussionTaken together, these results suggested that sodium butyrate-induced autophagy was mediated by endoplasmic reticulum stress, and that preventing autophagy by blocking the endoplasmic reticulum stress response enhanced sodium butyrate-induced apoptosis. These results provide novel insights into the anti-tumor mechanisms of butyric acid.

Highlights

  • Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer-related death worldwide

  • Sodium butyrate treatment markedly enhanced the expression of endoplasmic reticulum stress-associated proteins, including binding immunoglobulin protein (BIP), C/EBP homologous protein (CHOP), protein disulfide isomerase (PDI), and IRE-1a

  • When endoplasmic reticulum stress was inhibited by pharmacological and genetic methods, the induction of BIP, PDI, inositol-requiring enzyme 1a (IRE1a), and light chain 3 (LC3)-II was blocked, but PARP cleavage was markedly enhanced

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer-related death worldwide. SCFAs have been shown to have anti-tumor effects related to induction of tumor cell death, and are currently being investigated as adjuvant therapies for colorectal cancer [5]. Butyrate preferentially induces apoptosis or necrosis compared to propionate in gastric cancer cells [5]. Sodium butyrate (NaB) inhibits cell cycle progression, promotes differentiation, and induces apoptosis and autophagy in several types of cancer cells, including CRC, lymphoma, and breast cancer cells [9,10,11,12]. It has been suggested that butyrate is the preferred energy source for normal colonocytes and supports homeostasis [13], but butyrate accumulates in cancerous colonocytes due to the Warburg effect where it functions as an HDAC inhibitor, inhibiting cell proliferation and stimulating apoptosis [14,15,16]. It is feasible that butyrate may function as a preventative agent in the colon of people who routinely eat fiber-rich diets, and as a therapeutic agent, especially in people who typically had eaten diets with low fiber content but subsequently changed to fiber-rich diets

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call